NRT

Redwood Scientific Technologies Inc. (OTC: RSCI) ("Redwood" or "the Company"), a pharmaceutical company, today announced a strategic shift in its product development priorities

Retrieved on: 
Thursday, April 18, 2024

NEW YORK, April 18, 2024 /PRNewswire/ -- Redwood Scientific Technologies Inc. (OTC: RSCI) ("Redwood" or "the Company"), a pharmaceutical company, today announced a strategic shift in its product development priorities.

Key Points: 
  • NEW YORK, April 18, 2024 /PRNewswire/ -- Redwood Scientific Technologies Inc. (OTC: RSCI) ("Redwood" or "the Company"), a pharmaceutical company, today announced a strategic shift in its product development priorities.
  • The New York-based firm will only focus on enhancing and expanding its nicotine replacement therapy (NRT) products, specifically TBX-FREE™ and TBX VAPE-FREE™.
  • "Given the alarming data linking e-cigarette use to serious health risks, Redwood is committed to advancing our development of TBX-FREE™ and TBX VAPE-FREE™ products," said Jason Cardiff,  CEO of Redwood Scientific Technologies.
  • Redwood believes that its TBX-FREE™ and TBX VAPE-FREE™ products will be innovative solutions in the realm of nicotine replacement therapy.

The Truth About ZONNIC: New Educational Campaign Tackles Misinformation About Nicotine Pouches

Retrieved on: 
Thursday, April 11, 2024

Frank Silva, President and CEO of ITCAN, stated, "Our new ZONNIC campaign fact checks what's being said about ZONNIC nicotine pouches and reflects our dedication to harm reduction and our commitment to help reduce smoking rates in Canada."

Key Points: 
  • Frank Silva, President and CEO of ITCAN, stated, "Our new ZONNIC campaign fact checks what's being said about ZONNIC nicotine pouches and reflects our dedication to harm reduction and our commitment to help reduce smoking rates in Canada."
  • Since launch in October, ZONNIC nicotine pouches and ITCAN have been targeted by anti-tobacco lobby groups and by the Federal Minister of Health with accusations and inaccuracies.
  • The company is now setting the record straight by shedding light on the truth about ZONNIC.
  • The launch of The Truth About ZONNIC campaign will allow ITCAN to dispel myths about ZONNIC nicotine pouches and to demonstrate how ITCAN has gone above and beyond to ensure ZONNIC is not accessible to youth.

Haute Residence and Frank D. Isoldi Continue Their Real Estate Partnership Into Thirteenth Year

Retrieved on: 
Wednesday, March 13, 2024

WESTFIELD, N.J., March 13, 2024 /PRNewswire-PRWeb/ -- A broker sales associate affiliated with the Westfield office of Coldwell Banker Residential Brokerage in New Jersey and Rockland County, New York, Frank has been a top agent in the company's Westfield East office for 18 consecutive years. Isoldi has earned the NJ REALTORS® Circle of Excellence Sales Award® at the uppermost Platinum Level every year from 2003-2023. In addition, Frank has been consistently named by New Jersey Monthly Magazine as a "Five Star Real Estate Agent," and he has been chosen by Coldwell Banker Global Luxury as a member of the prestigious International Luxury Alliance Network as well as a Global Luxury Alliance Ambassador. A Westfield native, Isoldi achieved these momentous accomplishments throughout his 30+ years of consistent sales success.

Key Points: 
  • Haute Residence and prominent New Jersey realtor Frank D. Isoldi continue their successful partnership into its 13th year.
  • As part of Haute Residence's network of top brokers, Isoldi is the sole real estate agent to represent the high-end real estate market exclusively in Westfield, New Jersey.
  • Isoldi has earned the NJ REALTORS® Circle of Excellence Sales Award® at the uppermost Platinum Level every year from 2003-2023.
  • Coldwell Banker Residential Brokerage in New Jersey and Rockland County, New York, is part of NRT LLC, the nation's largest residential real estate brokerage company.

Health groups call on Federal government to deliver on its commitment to protect kids against nicotine addiction

Retrieved on: 
Monday, February 19, 2024

While the government's existing proposal would exempt mint/menthol, health groups have argued that a complete ban on non-tobacco flavours is required to protect young people from nicotine addiction, as mint/menthol is the second-most popular flavour amongst youth and young adults .

Key Points: 
  • While the government's existing proposal would exempt mint/menthol, health groups have argued that a complete ban on non-tobacco flavours is required to protect young people from nicotine addiction, as mint/menthol is the second-most popular flavour amongst youth and young adults .
  • The ad also calls for swift action to protect minors against the sale and promotion of nicotine pouches, namely by making them a prescription-only product.
  • Making nicotine pouches available on a prescription-only basis would give time to both federal and provincial governments to establish a proper regulatory framework.
  • We hope that the government will be consistent in protecting kids from nicotine addiction and will rapidly move to ban all flavours in vaping products.

NEO Credit (NRT) Is Now Available for Trading on LBank Exchange

Retrieved on: 
Tuesday, January 23, 2024

Users of LBank Exchange can brace themselves for the NRT/USDT trading pair, which will went live already.

Key Points: 
  • Users of LBank Exchange can brace themselves for the NRT/USDT trading pair, which will went live already.
  • NEO Credit (NRT), a key utility and gas token within the My NEO Group ecosystem, has been officially listed on LBank Exchange.
  • The listing of NRT on LBank Exchange marks a significant stride in My NEO Group's vision to integrate digital currencies with traditional financial systems.
  • The wider community is invited to explore the extensive potential of NEO Credit through the resources available on the My NEO Group website.

LUCY ANNOUNCES PUBLICATION OF PEER-REVIEWED BEHAVIORAL STUDY OF ITS NON-MEDICINAL NICOTINE GUM

Retrieved on: 
Wednesday, January 10, 2024

LAS VEGAS, Jan. 10, 2024 /PRNewswire/ -- Lucy Goods (LUCY), an innovator of modern oral nicotine products, is proud to announce the publication of a behavioral study in Harm Reduction Journal.

Key Points: 
  • LAS VEGAS, Jan. 10, 2024 /PRNewswire/ -- Lucy Goods (LUCY), an innovator of modern oral nicotine products, is proud to announce the publication of a behavioral study in Harm Reduction Journal.
  • Titled " Perceptions, intentions, and actual use of a consumer nicotine gum ," the study is the first to assess the potential of non-medicinal nicotine gum to switch adults who smoke to a potentially less harmful alternative.
  • Lucy's behavioral study in Harm Reduction Journal is first to assess nicotine gum as less harmful smoking alternative.
  • Quitting or cutting down consumption of cigarettes, vapes and other tobacco products were the most common motivation for trying LUCY Gum.

HealthPartners now offering new digital tobacco cessation tool

Retrieved on: 
Thursday, December 14, 2023

While rates of smoking decreased during the pandemic, overall tobacco cessation may have slowed – and that’s something HealthPartners is working to change with a new app-based tool called Pivot Breathe.

Key Points: 
  • While rates of smoking decreased during the pandemic, overall tobacco cessation may have slowed – and that’s something HealthPartners is working to change with a new app-based tool called Pivot Breathe.
  • HealthPartners is offering the program first to its fully insured, small business plans and expects to expand eligibility in the coming year.
  • Members who are tobacco users in the small group market can enroll in Pivot’s tobacco cessation program for six months with no cost-sharing.
  • However, data routinely shows that a majority of tobacco users want to quit, which HealthPartners hopes to capitalize on by offering the new tool.

Qnovia, Inc. announces positive results from first-in-human pharmacokinetic and safety study of lead asset QN-01, a prescription inhaled smoking cessation therapy

Retrieved on: 
Wednesday, November 29, 2023

Qnovia, Inc., a pharma company developing inhaled therapeutics across a variety of indication areas leveraging its proprietary inhaled drug delivery platform, the RespiRxTM, today announced positive results from its first in-human study of QN-01, the company’s lead asset.

Key Points: 
  • Qnovia, Inc., a pharma company developing inhaled therapeutics across a variety of indication areas leveraging its proprietary inhaled drug delivery platform, the RespiRxTM, today announced positive results from its first in-human study of QN-01, the company’s lead asset.
  • QN-01 is an inhaled smoking cessation therapy that is currently being evaluated in the U.S. under FDA’s Center for Drug Evaluation and Research (CDER) and in the U.K. by the Medicines and Healthcare Products Regulatory Agency (MHRA).
  • “We are delighted to share that QN-01 demonstrated a superior pharmacokinetic profile compared to an existing inhaled NRT and was well tolerated.
  • The drug-device combination was well tolerated with no severe adverse events and few minor adverse events typical of inhaled nicotine.

IMPERIAL TOBACCO CANADA STANDS BY ZONNIC AS A TOBACCO HARM REDUCTION TOOL

Retrieved on: 
Wednesday, November 15, 2023

MONTREAL, Nov. 15, 2023 /CNW/ - Despite the criticism from health groups, Imperial Tobacco Canada (ITCAN) believes that ZONNIC, a Nicotine Replacement Therapy (NRT) product authorized for sale by Health Canada, will help adult Canadians smokers quit.

Key Points: 
  • MONTREAL, Nov. 15, 2023 /CNW/ - Despite the criticism from health groups, Imperial Tobacco Canada (ITCAN) believes that ZONNIC, a Nicotine Replacement Therapy (NRT) product authorized for sale by Health Canada, will help adult Canadians smokers quit.
  • "I want to be absolutely clear, ZONNIC is not a tobacco product.
  • "It is licensed, regulated and advertised in the same way as any other smoking cessation product on the market.
  • ZONNIC is not promoted any differently than any other competing smoking cessation product in Canada.

Quit for Good Signs Global Statement of Support for Tobacco Harm Reduction

Retrieved on: 
Tuesday, November 7, 2023

Quit For Good is a non-profit organization promoting harm reduction to mitigate the damage caused by cigarette smoke on human health.

Key Points: 
  • Quit For Good is a non-profit organization promoting harm reduction to mitigate the damage caused by cigarette smoke on human health.
  • It is one of the 14 scientific organizations in four continents who support the consensus statement of SCOHRE that the WHO FCTC should not ignore the evidence in support of THR any more.
  • It is also one of the two organizations based in the Philippines that signed the statement, the other being the Harm Reduction Alliance of the Philippines (HARAP).
  • He said providing safer nicotine products to reduce harm for smokers is common sense as smokers are already offered nicotine replacement therapy (NRT) to quit or reduce harm.